---
schema_version: "secwatch.filing_event.v1"
accession: "0001425450-25-000012"
form_type: "8-K"
ticker: "KIDS"
cik: "0001425450"
company_name: "ORTHOPEDIATRICS CORP"
filed_at: "2025-03-04T23:59:59+00:00"
generated_at: "2026-05-25T13:39:02.760500+00:00"
event_type: "earnings"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# OrthoPediatrics reports record FY2024 revenue of $204.7M, up 38% YoY; Q4 adjusted EBITDA doubles to $3.0M

## Summary
- Full year 2024 revenue $204.7M, up 38% from $148.7M in 2023; Q4 revenue $52.7M, up 40% YoY.
- Full year adjusted EBITDA $8.5M vs $5.0M in 2023; Q4 adjusted EBITDA $3.0M, more than double $1.3M.
- Net loss widened to $37.8M in 2024 from $21.0M in 2023; Q4 net loss $16.1M ($0.69/sh) vs $6.7M ($0.29/sh).
- FY2025 guidance: revenue $235-242M (15-18% growth), adjusted EBITDA $15-17M.

## SEC filing metadata
- accession: 0001425450-25-000012
- form_type: 8-K
- ticker: KIDS
- cik: 0001425450
- company_name: ORTHOPEDIATRICS CORP
- filed_at: 2025-03-04T23:59:59+00:00
- event_type: earnings
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 2.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1425450/000142545025000012/0001425450-25-000012-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1425450/000142545025000012/kids-20250304.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001425450-25-000012
- JSON: https://secwatch.observer/filing/0001425450-25-000012.json
- Plain text: https://secwatch.observer/filing/0001425450-25-000012.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.